Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 4, 2022

Primary Completion Date

October 30, 2025

Study Completion Date

November 30, 2025

Conditions
Rheumatic DiseasesFertility DisordersPregnancy, High RiskPregnancy ComplicationsImmunologic Disease
Interventions
OTHER

collection and analysis of treatments and procedures already performed by normal clinical practice

The patients' anthropometric variables; laboratory test results; PMA techniques (types of fertilization/drugs used for stimulation) and the outcome of the eventual pregnancy (ongoing treatment during the pregnancy itself, development of maternal/fetal complications, such as hypertension, preeclmpsia, thrombotic events, renal failure, disease flare, neonatal outcome) and data on the type of ovarian stimulation drug treatment.

Trial Locations (1)

Unknown

RECRUITING

San Raffaele Hospital, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER